Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LYMPHOARESIS
NCT04742374Phase 1Completed
- Sponsor
- CHU Nîmes
- Start
- Mar 2021
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 1, open-label trial in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) (2 arms), sponsored by CHU Nîmes. Primary endpoints: TH1 cells count, TH17 cells count and 1 more. Started Mar 2021; status: completed.
02
Conditions
chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
Beyond the preview
Go deeper on NCT04742374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04742374.